Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012 (2012), Article ID 819356, 8 pages
http://dx.doi.org/10.5402/2012/819356
Clinical Study

The Incidence of Various Antiphospholipid Antibodies, Measured by Commercial-Based Laboratory, with Recurrent Spontenous Abortion and the Impact of Their Profiles on Reproductive Outcome with Active Anticoagulant Therapy

Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan

Received 8 November 2011; Accepted 15 December 2011

Academic Editor: A. Martin-Hidalgo

Copyright © 2012 Nagayoshi Umehara and Tadao Tanaka. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lockshin, M. Druzin, S. Goei et al., “Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus,” The New England Journal of Medicine, vol. 313, no. 3, pp. 152–156, 1985. View at Google Scholar
  2. D. Branch, J. Scott, N. Kochenour, and E. Hershgold, “Obstetric complications associated with the lupus anticoagulant,” New England Journal of Medicine, vol. 313, no. 21, pp. 1322–1326, 1985. View at Google Scholar · View at Scopus
  3. E. Harris, J. Chan, R. Asherton, V. Aber, A. Gharavi, and G. Hughes, “Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test,” Archives of Internal Medicine, vol. 146, no. 11, pp. 2153–2156, 1986. View at Google Scholar
  4. G. Hughes, N. Harris, and A. Gharavi, “The anticardiolipin syndrome,” The Journal of Rheumatology, vol. 13, no. 3, pp. 486–489, 1986. View at Google Scholar · View at Scopus
  5. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of classification criteria for definite anti-phospholipid syndrome (APS),” Journal of Thrombosis, vol. 4, no. 2, pp. 295–306, 2006. View at Google Scholar
  6. M. Empson, M. Lassere, J. Craig, and J. Scott, “Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002859, 2005. View at Google Scholar · View at Scopus
  7. R. Rai, H. Cohen, M. Dave, and L. Regan, “Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies),” British Medical Journal, vol. 314, no. 7076, pp. 253–257, 1997. View at Google Scholar · View at Scopus
  8. N. S. Rote, D. Dostal-Johnson, and D. W. Branch, “Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin,” American Journal of Obstetrics and Gynecology, vol. 163, no. 2, pp. 575–584, 1990. View at Google Scholar · View at Scopus
  9. T. Sugi, J. Katsunuma, S. Izumi, J. A. Mclntyre, and T. Makino, “Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses,” Fertility and Sterility, vol. 71, no. 6, pp. 1060–1065, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Sugi, H. Matsubayasi, A. Inomo, L. Dan, and T. Makino, “Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss,” The Journal of Obstetrics and Gynaecology Research, vol. 30, no. 4, pp. 326–332, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. D. L. Yetman and W. H. Kutteh, “Antiphospholipid antibody panels and recurrent pregnancy loss. Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies,” Fertility and Sterility, vol. 66, no. 4, pp. 540–546, 1996. View at Google Scholar · View at Scopus
  12. A. Tincani, M. Filippini, and M. Scarsi, “European attempts for the standardisation of the antiphospholipid antibodies,” Lupus, vol. 18, no. 10, pp. 913–919, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. Thiagarajan, V. Pengo, and S. S. Shapiro, “The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants,” Blood, vol. 68, no. 4, pp. 869–874, 1986. View at Google Scholar · View at Scopus
  14. N. Ozawa, T. Makino, H. Matsubayashi et al., “β2-GPI-dependent and independent binding of anticardiolipin antibodies in patients with recurrent spontaneous abortions,” Journal of Clinical Laboratory Analysis, vol. 8, no. 5, pp. 255–259, 1994. View at Google Scholar · View at Scopus
  15. E. Matsuura, Y. Igarashi, M. Fujimoto et al., “Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor,” Journal of Immunology, vol. 148, no. 12, pp. 3885–3891, 1992. View at Google Scholar · View at Scopus
  16. T. Sugi and J. A. McIntyre, “Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex,” Blood, vol. 86, no. 8, pp. 3083–3089, 1995. View at Google Scholar · View at Scopus
  17. J. A. McIntyre, D. R. Wagenknecht, and W. P. Faulk, “Antiphospholipid antibodies in heart transplant recipients,” Clinical Cardiology, vol. 18, no. 10, pp. 575–580, 1995. View at Google Scholar · View at Scopus
  18. M. D. Lockshin, T. Qamar, M. L. Druzin, and S. Goei, “Antibody to cardiolipin, lupus anticoagulant, and fetal death,” Journal of Rheumatology, vol. 14, no. 2, pp. 259–262, 1987. View at Google Scholar · View at Scopus
  19. R. S. Rai, K. Clifford, H. Cohen, and L. Regan, “High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies,” Human Reproduction, vol. 10, no. 12, pp. 3301–3304, 1995. View at Google Scholar · View at Scopus
  20. R. M. Silver, T. F. Porter, I. van Leeuween, G. Jeng, J. R. Scott, and D. W. Branch, “Anticardiolipin antibodies: clinical consequences of ‘low titers’,” Obstetrics and Gynecology, vol. 87, no. 4, pp. 494–500, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wu and M. D. Stephenson, “Obstetrical antiphospholipid syndrome,” Seminars in Reproductive Medicine, vol. 24, no. 1, pp. 40–53, 2006. View at Google Scholar · View at Scopus
  22. W. Matzner, P. Chong, G. Xu, and W. Ching, “Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 1, pp. 27–30, 1994. View at Google Scholar · View at Scopus
  23. K. Aoki, Y. Hayashi, Y. Hirao, and Y. Yagami, “Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss,” American Journal of Reproductive Immunology, vol. 29, no. 2, pp. 82–87, 1993. View at Google Scholar · View at Scopus